40 Stocks Moving In Wednesday’s Mid-Day Session Benzinga
Melinta Therapeutics, Inc. (NASDAQ: MLNT) shares climbed 143.4% to $4.82 after the company reported FDA approval of its BAXDELA sNDA for the treatment …
40 Stocks Moving In Wednesday’s Mid-Day Session Benzinga
Melinta Therapeutics, Inc. (NASDAQ: MLNT) shares climbed 143.4% to $4.82 after the company reported FDA approval of its BAXDELA sNDA for the treatment …